Surgical treatment and prognosis of metastatic ovarian carcinoma from gastrointestinal tract
10.3760/cma.j.issn.1007-631X.2010.09.022
- VernacularTitle:胃肠道来源卵巢转移瘤的手术治疗及预后
- Author:
Jingzhu ZHAO
;
Rupeng ZHANG
;
Xuejun WANG
;
Gang WANG
;
Bin KE
;
Han LIANG
- Publication Type:Journal Article
- Keywords:
Ovarian neoplasms;
Neoplasm metastasis;
Surgical procedures,operative;
Prognosis
- From:
Chinese Journal of General Surgery
2010;25(9):759-762
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the treatment and prognosis of metastatic ovarian carcinoma from gastrointestinal tract. Methods The clinical data of 110 patients with metastatic ovarian carcinoma were reviewed. Results The median age of 110 patients was 45 years old.Metastatic ovarian carcinomas were from stomach (74.5%),and colon and rectum (25.5%).The median overall survival time of 110 patients was 16.3 months,and the median progression-free survival time of 110 patients was 8.2 months.Survival rates of 1-,3-and 5-year were 68.4% 、15.4% and 2.5%,respectively.In univariate survival analysis,different origins(P ＜ 0.01),extent of recurrent disease (P ＜ 0.01),cytoreductive surgery (P ＜0.01),intraperitoneal chemotherapy (P ＜ 0.05) and pathologic type of metastatic ovarian carcinoma (P ＜0.05) were correlated with the prognosis.Age,menstrual history,ascites,and chemotherapy have less effect on prognosis (P ＞ 0.05).In multivariable analysis,different origins (P ＜ 0.01),extent of recurrent disease(P ＜ 0.05) and cytoreductive surgery (P ＜ 0.01) were confirmed to be independent factor. Conclusion Patients with metastatic ovarian carcinomas have poor prognosis.Optimal cytoreduction significantly prolongs overall survival in patients with metastatic ovarian carcinoma from gastrointestinal tract.
